How does MT-1 (Melanotan I) work?
Alpha-MSH analog that binds melanocortin receptors (primarily MC1R). MC1R activation in melanocytes triggers the eumelanin-production pathway, deepening skin pigment with UV exposure. In plain terms, MT-1 (Melanotan I) is tanning peptide that darkens your skin by driving melanin production. An alpha-MSH analog with a cleaner side effect profile than MT-2. Mechanistic detail like this comes largely from preclinical and early research, the human picture is limited.
What people use it for
- Light-skinned users wanting baseline tan with less UV time
- People who tried MT-2 and didn't tolerate the libido / nausea hit
- Anyone running it under medical context (Afamelanotide is the drug version)
References
- Afamelanotide for Erythropoietic Protoporphyria (Scenesse approval data) — Langendonk JG et al., NEJM, 2015
- Skin pigmentation and pharmacokinetics of melanotan-I in humans — Ugwu SO, Blanchard J, Dorr RT, Levine N, et al.; Biopharmaceutics & Drug Disposition; 1997
- Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications — Wu J, Cotliar R; Journal of Drugs in Dermatology; 2021
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on MT-1 (Melanotan I)
Last updated 2026-06-06.